128 related articles for article (PubMed ID: 27523643)
1. Retraction notice to "Identification of novel aminothiazole and aminothiadiazole conjugated cyanopyridines as selective CHK1 inhibitors" [Eur. J. Med. Chem. 92 (2015) 459-470].
Gomha SM; Abdulla MM; Abou-Seri SM
Eur J Med Chem; 2016 Oct; 121():939. PubMed ID: 27523643
[No Abstract] [Full Text] [Related]
2. Identification of novel aminothiazole and aminothiadiazole conjugated cyanopyridines as selective CHK1 inhibitors.
Gomha SM; Abdulla MM; Abou-Seri SM
Eur J Med Chem; 2015 Mar; 92():459-70. PubMed ID: 25594740
[TBL] [Abstract][Full Text] [Related]
3. Retraction notice to "Synthesis and biological evaluation of [1,2,4]triazino[4,3-a] benzimidazole acetic acid derivatives as selective aldose reductase inhibitors" [Eur. J. Med. Chem. (2010) 909-914].
Eur J Med Chem; 2011 Oct; 46(10):5225. PubMed ID: 22049548
[No Abstract] [Full Text] [Related]
4. Retraction notice to “Synthesis and biological screening of some novel amidocarbamate derivatives of ketoprofen” [Eur. J. Med. Chem. (2010) 3162-3168].
Eur J Med Chem; 2012 Jan; 47(1):626. PubMed ID: 22355807
[No Abstract] [Full Text] [Related]
5. Retraction notice to “Proton-pumping-ATPase-targeted antifungal activity of cinnamaldehyde based sulfonyl tetrazoles” [Eur. J. Med. Chem. 48 (2012) 363-370].
Eur J Med Chem; 2012 Nov; 57():483. PubMed ID: 22640886
[No Abstract] [Full Text] [Related]
6. Corrigendum to <'Synthesis and biological evaluation of 2,6-disubstituted-9H-purine, 2,4-disubstitued-thieno[3,2-d]pyrimidine and -7H-pyrrolo[2,3-d] pyrimidine analogues as novel CHK1 inhibitors' [Eur. J. Med. Chem. 151 (2018) 836-848].
Tian C; Han Z; Li Y; Wang M; Yang J; Wang X; Zhang Z; Liu J
Eur J Med Chem; 2019 Jul; 173():184. PubMed ID: 31003059
[No Abstract] [Full Text] [Related]
7. Corrigendum to "Identification of novel β-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents" [Eur. J. Med. Chem. 152 (2018) 148-159].
Ghoshal A; Kumar A; Yugandhar D; Sona C; Kuriakose S; Nagesh K; Rashid M; Singh SK; Wahajuddin M; Yadav PN; Srivastava AK
Eur J Med Chem; 2018 Aug; 156():628-630. PubMed ID: 30031973
[No Abstract] [Full Text] [Related]
8. Retraction notice to kinase inhibitors and airway inflammation [Eur. J. Pharmacol 533/1-3 (2006) 118 – 132 of kinase inhibitors and airway inflammation].
Eur J Pharmacol; 2012 May; 683(1-3):340. PubMed ID: 22679637
[No Abstract] [Full Text] [Related]
9. Retraction notice to "Sannastatin, a novel toxic macrolactam polyketide glycoside produced by actinomycete Streptomyces sannanensis" [Bioorg. Med. Chem. Lett. 21 (2011) 3905-3908].
Yang SX; Gao JM; Zhang AL; Laatsch H
Bioorg Med Chem Lett; 2017 Sep; 27(17):4219. PubMed ID: 28826506
[No Abstract] [Full Text] [Related]
10. Retraction notice to "3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis" [Bioorg. Med. Chem. 19 (2011) 5175-82].
Bioorg Med Chem; 2015 Jan; 23(1):272. PubMed ID: 25671237
[No Abstract] [Full Text] [Related]
11. Retraction notice to "A computational docking study for prediction of binding mode of diospyrin and derivatives: Inhibitors of human and leishmanial DNA topoisomerase-I" [Bioorg. Med. Chem. Lett. 17 (2007) 4604-4612].
Bioorg Med Chem Lett; 2007 Sep; 17(18):5281. PubMed ID: 17987674
[No Abstract] [Full Text] [Related]
12. Retraction notice to 'Corrigendum to "3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis"' [Bioorg. Med. Chem. 20 (2012) 5668-5668].
Bioorg Med Chem; 2014 Dec; 22(23):6726. PubMed ID: 25756091
[No Abstract] [Full Text] [Related]
13. Retraction notice to 'Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors' [Bioorg Med Chem 22 (2014) 3850-3855].
Bioorg Med Chem; 2015 Aug; 23(15):5078. PubMed ID: 26425745
[No Abstract] [Full Text] [Related]
14. Retraction notice to "A novel bioartificial myocardial tissue and its prospective use in cardiac surgery" [Eur. J. Cardiothorac. Surg. 22 (2002) 238-243].
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1554. PubMed ID: 22191097
[No Abstract] [Full Text] [Related]
15. Corrigendum to "Synthesis of the pH-sensitive nanoparticles based on the acylhydrazone bonds conjugated doxorubicin and studies on their in vivo anti-tumor effects" [Eur. J. Med. Chem. 260 (2023) 115715].
Shi Y; Pan X; Xu S; Zhu H; Zhao B; Sun Z; Dong R; Li N; Hou X; Yang X
Eur J Med Chem; 2023 Dec; 262():115887. PubMed ID: 37867086
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Optimization of physicochemical properties for 4-Anilinoquinazoline inhibitors of trypanosome proliferation" [Eur. J. Med. Chem. 141 (2017) 446-459].
Woodring JL; Bachovchin KA; Brady KG; Gallerstein MF; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Pollastri MP
Eur J Med Chem; 2018 May; 152():515. PubMed ID: 29754075
[No Abstract] [Full Text] [Related]
17. Corrigendum to "Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis" [Eur. J. Med. Chem 209 (2021) 112942].
Faraji A; Oghabi Bakhshaiesh T; Hasanvand Z; Motahari R; Nazeri E; Boshagh MA; Firoozpour L; Mehrabi H; Khalaj A; Esmaeili R; Foroumadi A
Eur J Med Chem; 2021 Mar; 214():113228. PubMed ID: 33550180
[No Abstract] [Full Text] [Related]
18. Corrigendum to "Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview" [Eur. J. Med. Chem. 194 (2020) 112260].
Mondal S; Adhikari N; Banerjee S; Amin SA; Jha T
Eur J Med Chem; 2020 Nov; 205():112642. PubMed ID: 32750565
[No Abstract] [Full Text] [Related]
19. Corrigendum to "Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors" [Eur. J. Med. Chem. 167 (2019) 1-9].
Patel H; Jadhav H; Ansari I; Pawara R; Surana S
Eur J Med Chem; 2020 Aug; 200():112413. PubMed ID: 32512481
[No Abstract] [Full Text] [Related]
20. Corrigendum to "Design, synthesis, and biological evaluation of 1,6-naphthyridine-2-one derivatives as novel FGFR4 inhibitors for the treatment of colorectal cancer" [Eur. J. Med. Chem. 259 (2023) 115703/5].
Fang B; Lai Y; Yan H; Ma Y; Ni Z; Zhu Q; Zhang J; Ye Y; Wang M; Wang P; Wang Y; Zhang S; Hui M; Wang D; Zhao Y; Li X; Wang K; Liu Z
Eur J Med Chem; 2024 Mar; 268():116230. PubMed ID: 38368135
[No Abstract] [Full Text] [Related]
[Next] [New Search]
